Description

Kazakhstan Pharmaceuticals & Healthcare Q1 2018 Description

BMI View: Kazakhstan's pharmaceutical market represents a significant growth opportunity for multinational drugmakers, which will be aided by pharmaceutical regulatory development and healthcare reforms. The gradual roll-out of drug pricing regulations will benefit drugmakers through reduced patient inequality in affordability and increased market transparency. We note that innovative drugmakers will continue to view the market as unattractive.